Cargando…

Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin

IDH1(R132H) (isocitrate dehydrogenase 1) mutations play a key role in the development of low-grade gliomas. IDH1(wt) converts isocitrate to α-ketoglutarate while reducing nicotinamide adenine dinucleotide phosphate (NADP(+)), whereas IDH1(R132H) uses α-ketoglutarate and NADPH to generate the oncomet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biedermann, Julia, Preussler, Matthias, Conde, Marina, Peitzsch, Mirko, Richter, Susan, Wiedemuth, Ralf, Abou-El-Ardat, Khalil, Krüger, Alexander, Meinhardt, Matthias, Schackert, Gabriele, Leenders, William P., Herold-Mende, Christel, Niclou, Simone P., Bjerkvig, Rolf, Eisenhofer, Graeme, Temme, Achim, Seifert, Michael, Kunz-Schughart, Leoni A., Schröck, Evelin, Klink, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966450/ https://www.ncbi.nlm.nih.gov/pubmed/31888244 http://dx.doi.org/10.3390/cancers11122028

Ejemplares similares

Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model
por: Clausing, Maximilian, et al.
Publicado: (2022)

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53
por: Wiedemuth, Ralf, et al.
Publicado: (2014)

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
por: Conde, Marina, et al.
Publicado: (2017)

Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs
por: Seifert, Michael, et al.
Publicado: (2020)

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
por: Abou-El-Ardat, Khalil, et al.
Publicado: (2017)

FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS
por: Cano-Galiano, Andrés, et al.
Publicado: (2021)

Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
por: Cano-Galiano, Andrés, et al.
Publicado: (2021)

Novel CIC Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing
por: Eisenreich, Sophie, et al.
Publicado: (2013)

A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
por: Golebiewska, Anna, et al.
Publicado: (2013)

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011)

Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort
por: William, Doreen, et al.
Publicado: (2021)

Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
por: Dao Trong, Philip, et al.
Publicado: (2018)

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes
por: Exner, Nadin D., et al.
Publicado: (2019)

Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
por: Sanzey, Morgane, et al.
Publicado: (2015)

Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
por: Fack, Fred, et al.
Publicado: (2017)

Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma
por: Makarevic, Anastasia, et al.
Publicado: (2020)

An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis
por: Pistorius, Steffen, et al.
Publicado: (2016)

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
por: Kurth, Ina, et al.
Publicado: (2015)

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
por: Jungk, Christine, et al.
Publicado: (2019)

Large-Scale Drug Screening in Patient-Derived IDH(mut) Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents
por: Dao Trong, Philip, et al.
Publicado: (2020)

Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020)

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
por: Ruiz-Rodado, Victor, et al.
Publicado: (2022)

Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
por: Al-Ali, Ruslan, et al.
Publicado: (2019)

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
por: Jungk, Christine, et al.
Publicado: (2016)

AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
por: Schuster, Anne, et al.
Publicado: (2020)

Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
por: Blanco-Carmona, Enrique, et al.
Publicado: (2023)

Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry
por: Longuespée, Rémi, et al.
Publicado: (2018)

A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition
por: Steiner, Gerald, et al.
Publicado: (2022)

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer
por: Kast, Karin, et al.
Publicado: (2012)

Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event
por: Lass, Ulrike, et al.
Publicado: (2012)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

IDH1 mutations induce organelle defects via dysregulated phospholipids
por: Lita, Adrian, et al.
Publicado: (2021)

Oligosarcomas, IDH-mutant are distinct and aggressive
por: Suwala, Abigail K., et al.
Publicado: (2021)

Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic Subclassification
por: Klink, Barbara, et al.
Publicado: (2010)

Rapid Label-Free Analysis of Brain Tumor Biopsies by Near Infrared Raman and Fluorescence Spectroscopy—A Study of 209 Patients
por: Galli, Roberta, et al.
Publicado: (2019)

Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
por: Jungk, Christine, et al.
Publicado: (2016)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair
por: Blankenstein, Leon J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4jl6m9l9q2msga6j5u5969siru